| Professional
Info eNEWSLETTER (eBoletín) Other Issues
|
PROPOFOL FDA LABEL
CHANGE -
TOP
You can express your opinions on this change to the FDA by visiting www.fda.gov and clicking on "Comment on Proposed Regulations" from the homepage. The petition number is 2005P-0267. For more information visit www.safepropofol.org. This is a non-SAMBA advocacy campaign intended to raise awareness on the risks associated with the FDA label change. The campaign website includes copies of the FDA petition as well as draft letters for advocates to send to the FDA.
Be
sure to attend the SAMBA 21st Annual Meeting Dr. TJ Gan will chair next year's Annual Meeting, with Dr. Peter Glass as
vice-chair.
Call for Abstracts and Residents' Travel Awards The Committee on Scientific Papers has issued a call for abstracts for the 21st Annual Meeting. The Society encourages residents in anesthesiology training programs to become more involved in SAMBA. The Society will issue a limited number of travel awards to anesthesiology residents whose scientific abstracts are accepted for presentation at the SAMBA 21st Annual Meeting. Electronic Abstract Submission Deadline: February 13, 2006
SAMBA is conducting a survey on the use of droperidol since the issuance of the FDA Black Box warning. Please take a moment to complete this brief, but important, survey. The survey consists of 20 questions and takes approximately two minutes to complete. in the survey here. Maintaining a vibrant organization requires input from our membership. The “SAMBA Survey” will become a regular feature on this site that will help us better assess the needs of the membership as well as to get basic survey information on various practice issues. © SOCIETY FOR AMBULATORY ANESTHESIA 520 N. Northwest Highway Park Ridge, Illinois 60068-2573 Tel: (847) 825-5586 Fax: (847) 825-5658 E-mail: samba@asahq.org |